ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $5.55B
1-Year Return 17.42%
This Quarter Return
+3.56%
1 Year Return
+17.42%
3 Year Return
+73.67%
5 Year Return
+135.73%
10 Year Return
+381.42%
AUM
$3.45B
AUM Growth
+$409M
Cap. Flow
+$323M
Cap. Flow %
9.36%
Top 10 Hldgs %
17.82%
Holding
345
New
47
Increased
96
Reduced
68
Closed
26

Sector Composition

1 Industrials 22.96%
2 Technology 19.42%
3 Consumer Discretionary 16.23%
4 Healthcare 9.64%
5 Financials 6.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SPWH icon
276
Sportsman's Warehouse
SPWH
$121M
$212K 0.01%
+26,503
New +$212K
PKOH icon
277
Park-Ohio Holdings
PKOH
$303M
$207K 0.01%
+3,569
New +$207K
CALD
278
DELISTED
Callidus Software, Inc.
CALD
$205K 0.01%
17,144
+3,486
+26% +$41.7K
TBI
279
Trueblue
TBI
$173M
$204K 0.01%
+7,393
New +$204K
HALO icon
280
Halozyme
HALO
$8.88B
$198K 0.01%
20,000
-15,076
-43% -$149K
NPKI
281
NPK International Inc.
NPKI
$886M
$182K 0.01%
14,580
+1,660
+13% +$20.7K
EXA
282
DELISTED
EXA Corporation
EXA
$178K 0.01%
15,768
+3,837
+32% +$43.3K
QTWO icon
283
Q2 Holdings
QTWO
$5.28B
$153K ﹤0.01%
+10,715
New +$153K
CSLT
284
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$152K ﹤0.01%
10,017
-4,983
-33% -$75.6K
LFCR icon
285
Lifecore Biomedical
LFCR
$281M
$151K ﹤0.01%
12,090
-19
-0.2% -$237
MDWD icon
286
MediWound
MDWD
$179M
$136K ﹤0.01%
+1,704
New +$136K
BLUE
287
DELISTED
bluebird bio
BLUE
$96K ﹤0.01%
+193
New +$96K
DYAX
288
DELISTED
DYAX CORPORATION
DYAX
$95K ﹤0.01%
+10,000
New +$95K
GMAN
289
DELISTED
Gordmans Stores, Inc.
GMAN
$63K ﹤0.01%
14,615
EEM icon
290
iShares MSCI Emerging Markets ETF
EEM
$19.3B
$12K ﹤0.01%
+288
New +$12K
BAC.WS.A
291
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$1K ﹤0.01%
90
SYK icon
292
Stryker
SYK
$150B
0
TEVA icon
293
Teva Pharmaceuticals
TEVA
$22B
0
ABBV icon
294
AbbVie
ABBV
$371B
0
ALKS icon
295
Alkermes
ALKS
$4.65B
0
AMGN icon
296
Amgen
AMGN
$151B
-113
Closed -$14K
BDX icon
297
Becton Dickinson
BDX
$54.2B
0
BMRN icon
298
BioMarin Pharmaceuticals
BMRN
$10.7B
0
BMY icon
299
Bristol-Myers Squibb
BMY
$94.2B
0
BSX icon
300
Boston Scientific
BSX
$160B
0